United Orthopedic (4129) - Cash Flow Conversion Efficiency
Based on the latest financial reports, United Orthopedic (4129) has a cash flow conversion efficiency ratio of 0.013x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (NT$51.73 Million ≈ $1.63 Million USD) by net assets (NT$4.01 Billion ≈ $126.18 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see 4129 company net worth for the company's overall valuation and market capitalisation.
United Orthopedic - Cash Flow Conversion Efficiency Trend (2015–2025)
This chart illustrates how United Orthopedic's cash flow conversion efficiency has evolved over time, based on yearly financial data.
United Orthopedic Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of United Orthopedic ranked by their cash flow conversion efficiency. Explore United Orthopedic cash earnings quality to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Jeju Air Co Ltd
KO:089590
|
0.262x |
|
Hancom Inc
KQ:030520
|
0.049x |
|
Ioneer Ltd
AU:INR
|
-0.009x |
|
Sanstar Ltd
NSE:SANSTAR
|
0.064x |
|
Lionheart Holdings
NASDAQ:CUB
|
0.000x |
|
Dreamus Company
KQ:060570
|
0.097x |
|
Outbrain Inc
NASDAQ:OB
|
0.184x |
|
Funkwerk AG
F:FEW
|
-0.023x |
Annual Cash Flow Conversion Efficiency for United Orthopedic (2015–2025)
The table below shows the annual cash flow conversion efficiency of United Orthopedic from 2015 to 2025. View United Orthopedic (4129) share price today for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | NT$4.20 Billion ≈ $132.46 Million |
NT$1.03 Billion ≈ $32.32 Million |
0.244x | +34.36% |
| 2024-12-31 | NT$3.95 Billion ≈ $124.45 Million |
NT$717.29 Million ≈ $22.60 Million |
0.182x | +63.81% |
| 2023-12-31 | NT$3.59 Billion ≈ $113.23 Million |
NT$398.43 Million ≈ $12.55 Million |
0.111x | +0.51% |
| 2022-12-31 | NT$3.09 Billion ≈ $97.35 Million |
NT$340.79 Million ≈ $10.74 Million |
0.110x | -7.03% |
| 2021-12-31 | NT$2.82 Billion ≈ $88.87 Million |
NT$334.64 Million ≈ $10.54 Million |
0.119x | -27.95% |
| 2020-12-31 | NT$2.93 Billion ≈ $92.15 Million |
NT$481.65 Million ≈ $15.17 Million |
0.165x | -1.89% |
| 2019-12-31 | NT$2.93 Billion ≈ $92.43 Million |
NT$492.45 Million ≈ $15.51 Million |
0.168x | +2943.61% |
| 2018-12-31 | NT$2.25 Billion ≈ $70.90 Million |
NT$12.41 Million ≈ $390.98K |
0.006x | +321.95% |
| 2017-12-31 | NT$2.22 Billion ≈ $69.88 Million |
NT$2.90 Million ≈ $91.33K |
0.001x | -98.68% |
| 2016-12-31 | NT$1.80 Billion ≈ $56.76 Million |
NT$179.03 Million ≈ $5.64 Million |
0.099x | -30.29% |
| 2015-12-31 | NT$1.77 Billion ≈ $55.86 Million |
NT$252.75 Million ≈ $7.96 Million |
0.143x | -- |
About United Orthopedic
United Orthopedic Corporation engages in the research, development, manufacture, and sale of orthopedic implants and surgical equipment in Taiwan, Asia, America, Europe, Africa, and Oceania. The company offers artificial hip joints, partial hip joints, joints for large trochanteric fractures, Moore hip prostheses, and customized artificial hip joints for individual tumor patients; artificial knee… Read more